In summary, our findings indicates that 6-gingerol-alleviation of NAFLD is related to 6-gingerol-induced regulation on the stability of the LKB1/STRAD/MO25 complex and the activation of LKB1. The gene discussed is STK11; the disease is metabolic dysfunction-associated steatotic liver disease.